Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.
Summary
- On March 31, 2024, BioAtla, Inc. withheld 572 shares of common stock from Eric Sievers, the Chief Medical Officer, to satisfy income tax obligations.
- The shares were withheld at a price of $3.44 per share.
- Following the transaction, Sievers directly owns 210,422 shares of BioAtla common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to insider transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction where shares were withheld to cover income tax obligations. |
| 04/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.